Anika To Participate in December 2024 Investor Conferences
Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company, announced its participation in three major investor conferences this December. The company will attend the 36th Annual Piper Sandler Healthcare Conference in New York on December 3rd, with a presentation at 10:30am ET. They will also participate in the Sidoti Small-Cap Virtual Conference on December 5th with a presentation at 10:45am ET, and the Benchmark Company 13th Annual Discovery One-on-One Investor Conference in New York on December 11th. Senior management, including CEO Dr. Cheryl Blanchard and CFO Steve Griffin, will conduct one-on-one investor meetings throughout these events.
Anika Therapeutics (NASDAQ: ANIK), un'azienda globale dedicata alla preservazione delle articolazioni, ha annunciato la sua partecipazione a tre importanti conferenze per investitori questo dicembre. L'azienda parteciperà al 36° Annuale Piper Sandler Healthcare Conference a New York il 3 dicembre, con una presentazione alle 10:30 ET. Parteciperanno anche al Sidoti Small-Cap Virtual Conference il 5 dicembre con una presentazione alle 10:45 ET e al Benchmark Company 13th Annual Discovery One-on-One Investor Conference a New York l'11 dicembre. I dirigenti senior, tra cui il CEO Dr. Cheryl Blanchard e il CFO Steve Griffin, condurranno incontri privati con gli investitori durante questi eventi.
Anika Therapeutics (NASDAQ: ANIK), una empresa global de preservación articular, anunció su participación en tres importantes conferencias para inversionistas este diciembre. La empresa asistirá a la 36ª Conferencia Anual de Salud Piper Sandler en Nueva York el 3 de diciembre, con una presentación a las 10:30 ET. También participarán en la Conferencia Virtual de Pequeñas Empresas de Sidoti el 5 de diciembre con una presentación a las 10:45 ET, y en la 13ª Conferencia Anual de Descubrimiento Uno a Uno de Benchmark Company en Nueva York el 11 de diciembre. La alta dirección, incluyendo a la CEO Dra. Cheryl Blanchard y al CFO Steve Griffin, llevará a cabo reuniones uno a uno con inversionistas durante estos eventos.
아니카 테라퓨틱스 (NASDAQ: ANIK), 글로벌 관절 보존 회사가 이번 12월 세 가지 주요 투자자 회의에 참가한다고 발표했습니다. 회사는 12월 3일 뉴욕에서 열리는 제36회 파이퍼 샌들러 헬스케어 컨퍼런스에 참석하며, 10:30 ET에 발표할 예정입니다. 12월 5일에는 시도티 소형주 가상 회의에 참석하며, 10:45 ET에 발표할 예정입니다. 또한, 12월 11일에는 뉴욕에서 열리는 벤치마크 회사 제13회 연례 발견 일대일 투자자 회의에도 참가합니다. 최고 경영진인 CEO Dr. Cheryl Blanchard와 CFO Steve Griffin은 이 이벤트 동안 투자자들과 일대일 미팅을 진행할 것입니다.
Anika Therapeutics (NASDAQ: ANIK), une entreprise mondiale dédiée à la préservation des articulations, a annoncé sa participation à trois grandes conférences pour investisseurs en décembre. L'entreprise assistera à la 36e Conférence Annuelle Piper Sandler Healthcare à New York le 3 décembre, avec une présentation à 10h30 ET. Ils participeront également à la Conférence Virtuelle Sidoti Small-Cap le 5 décembre avec une présentation à 10h45 ET, ainsi qu'à la 13e Conférence Annuelle de Découverte en tête-à-tête de Benchmark Company à New York le 11 décembre. La direction, y compris le PDG Dr. Cheryl Blanchard et le directeur financier Steve Griffin, mènera des réunions individuelles avec des investisseurs lors de ces événements.
Anika Therapeutics (NASDAQ: ANIK), ein globales Unternehmen zur Gelenkerhaltung, hat die Teilnahme an drei wichtigen Investorenkonferenzen im Dezember bekannt gegeben. Das Unternehmen wird am 3. Dezember an der 36. jährlichen Piper Sandler Healthcare Conference in New York teilnehmen und um 10:30 Uhr ET präsentieren. Am 5. Dezember nehmen sie außerdem an der Sidoti Small-Cap Virtual Conference teil und präsentieren um 10:45 Uhr ET, sowie an der 13. jährlichen Discovery One-on-One Investorenkonferenz der Benchmark Company in New York am 11. Dezember. Die Unternehmensführung, einschließlich CEO Dr. Cheryl Blanchard und CFO Steve Griffin, wird während dieser Veranstaltungen Einzelgespräche mit Investoren führen.
- None.
- None.
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will participate in the following upcoming conferences.
36th Annual Piper Sandler Healthcare Conference in New York, NY on December 3rd. Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer, are scheduled to present at 10:30am ET. Management will also participate in one-on-one investor meetings throughout the event.
Sidoti Small-Cap Virtual Conference on December 5th. Steve Griffin, Executive Vice President and Chief Financial Officer, is scheduled to present at 10:45am ET. Mr. Griffin will also participate in one-on-one investor meetings throughout the event.
The Benchmark Company 13th Annual Discovery One-on-One Investor Conference in New York, NY on December 11th. Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer will participate in one-on-one investor meetings throughout the event.
For more information about these events or to schedule a one-on-one meeting with Anika’s senior management, please contact Anika’s Investor Relations at investorrelations@anika.com.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
What investor conferences will Anika Therapeutics (ANIK) attend in December 2024?
When is Anika Therapeutics (ANIK) presenting at the Piper Sandler Healthcare Conference?
What time is Anika's (ANIK) presentation at the Sidoti Small-Cap Virtual Conference?
How can investors schedule meetings with Anika (ANIK) management at these conferences?
